Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on May 5, 2026, to report its financial results for the quarter ended March 31, 2026. The filing primarily furnished a press release containing these results, which is attached as Exhibit 99.1. Investors should note that this information is being furnished under Item 2.02 and is not considered "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings, unless specifically stated. While the specific financial figures from the press release are not detailed within the 8-K text itself, this report serves as the official notification to the market of IDEXX's first-quarter performance. Investors seeking detailed insights into revenue, profitability, and any forward-looking statements will need to refer to the furnished press release (Exhibit 99.1).
Key Highlights
- 1IDEXX Laboratories announced first quarter financial results for the period ended March 31, 2026.
- 2The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The filing is made under Item 2.02 (Results of Operations and Financial Condition).
- 4Information furnished under Item 2.02 is not deemed "filed" for Section 18 purposes unless expressly incorporated by reference.
- 5The press release contains the full details of the company's financial performance for the quarter.
- 6The Chief Financial Officer, Andrew Emerson, signed the report.